2011
DOI: 10.1016/j.bmc.2011.07.033
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
54
0
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 87 publications
(55 citation statements)
references
References 42 publications
0
54
0
1
Order By: Relevance
“…What more, some other pharmacological activity were also been found in those mono-carbonyl curcumin analogues. such as antioxidant [64][65][66], anti-inflammatory [67,68], anti-bacterial [69], anti-AD [70], with which the class of compounds will having good development prospects.…”
Section: Resultsmentioning
confidence: 99%
“…What more, some other pharmacological activity were also been found in those mono-carbonyl curcumin analogues. such as antioxidant [64][65][66], anti-inflammatory [67,68], anti-bacterial [69], anti-AD [70], with which the class of compounds will having good development prospects.…”
Section: Resultsmentioning
confidence: 99%
“…An 8-to 16 Å-wide rigid linker must separate two aromatic portions, and a hydroxylic group on one or both aromatic portions respectively ensures or increases Ab affinity [193]. The symmetrical, constrained piperidine-bispiperazine curcumin derivative 6.13 [194] ( Figure 6.6) shows improved physicochemical properties, bioavailability, and stability. It is a more potent inhibitor of Ab aggregation, anti-oxidant, and metal-chelating agent than curcumin in cell-free assays [194].…”
Section: Interfering With (Neuro)toxic Tau Species In the Aggregationmentioning
confidence: 97%
“…It is a more potent inhibitor of Ab aggregation, anti-oxidant, and metal-chelating agent than curcumin in cell-free assays [194]. It acts on Ab peptides by disfavoring the conformational transition to aggregationprone b-sheets, hindering the formation of both Ab fibrils and oligomers in an Ab aggregation assay, and decreasing oxidative stress in SH-SY5Y cells [194].…”
Section: Interfering With (Neuro)toxic Tau Species In the Aggregationmentioning
confidence: 99%
“…Moreover, it has been reported that curcumin has poor bioavailability and absorption, rapid metabolism, and systemic elimination, which contributes to a reduction in its redox-potency (Table 3). Recent studies suggest that curcumin derivatives may cross the blood-brain barrier potentially increasing the efficacy of these compounds in brain-specific diseases (15,71). These results suggest the translational potential of natural product SOD-inducers may be questionable and tissue-specific; however, for various disease types SODinducers and their derivatives potentially have broad applicability in disease prevention.…”
mentioning
confidence: 99%